-rich artificial cerebrospinal fluid (aCSF) causes larger sympathetic and pressor responses in Dahl salt-sensitive (S) than -resistant (R) or Wistar rats. Enhanced activity of the aldosterone-"ouabain" pathway or decreased nitric oxide (NO) release may contribute to this enhanced responsiveness. Where in the brain these mechanisms interact is largely unknown. The present study evaluated whether Na ϩ in the paraventricular nucleus (PVN) causes larger pressor responses in Dahl S (SS/Mcw) than R (Dahl SS.BN13) rats and whether mineralocorticoid receptors, benzamil-blockable Na ϩ channels, "ouabain," angiotensin type 1 receptors, or NO mediates these enhanced responses. Na ϩ -rich aCSF in the PVN caused 30 -40% larger increases in blood pressure and heart rate in Dahl S than R or Wistar rats, whereas responses to ouabain, ANG II, or N -nitro-L-arginine methyl ester hydrochloride (L-NAME) in the PVN were the same. These responses to Na ϩ were not affected by eplerenone, benzamil, or Fab fragments, whereas they were fully blocked by losartan, in Dahl S and R rats. L-NAME enhanced them more in Dahl R than S rats, thereby equalizing the responses in the two strains. Pressor responses to L-NAME in the PVN were attenuated by a high-salt diet in Dahl S, but not R, rats. The results indicate that acute and chronic increases in Na ϩ concentration in the PVN inhibit NO release in the PVN of Dahl S, but not R, rats, thereby contributing to the enhanced pressor responses to Na ϩ in Dahl S rats. paraventricular nucleus; ouabain; angiotensin type 1 receptors; nitric oxide; blood pressure (18, 35) and hypothalamic aldosterone and ouabain-like compounds ("ouabain") (21, 23, 42) and causes sympathoexcitation and hypertension in Dahl salt-sensitive (S), but not salt-resistant (R) or Wistar, rats (18, 34, 39 ). An increase in neural responsiveness to CSF [Na ϩ ] appears to contribute to salt sensitivity in Dahl S rats, since intracerebroventricular infusion of Na ϩ -rich artificial CSF (aCSF) causing the same increases in CSF [Na ϩ ] as in Dahl S rats on a high-salt diet, induces significantly larger increases in renal sympathetic nerve activity (SNA), blood pressure (BP), and heart rate (HR) in Dahl S than R or Wistar rats (20). Studies in congenic strains (14) indicate that the mechanisms contributing to the increase in CSF [Na ϩ ] in Dahl S rats on a high-salt diet and the enhanced central sensitivity to Na ϩ appear to be different. Chronic intracerebroventricular infusion of aldosterone combined with slightly higher-than-physiological CSF [Na ϩ ] leads to increases in hypothalamic "ouabain," sympathetic hyperactivity, and hypertension in Dahl S, but not R, rats (19). Because renal SNA, BP, and HR responses to intracerebroventricular injection of plant ouabain are similar in Dahl S and R rats (20, 51), mechanisms leading to enhanced release of "ouabain" may contribute to the enhanced neural responses to Na ϩ and aldosterone in Dahl S rats. However, the actual mechanisms contributing to the increased neuronal responsiveness to CSF [Na ϩ ] in Dahl S rats remain unknown. Neurons in the paraventricular nucleus (PVN) play an important role in mediating hypertension in Dahl S rats on a high-salt diet, since lesioning the PVN prevents the increase in BP (11). Increases in CSF [Na ϩ ] may excite Na ϩ -sensitive nuclei in the lamina terminalis, such as the subfornical organ (6). This increased neuronal activity can be relayed to parvocellular neurons of the PVN projecting to the intermediolateral cell column or rostral ventrolateral medulla, thereby increasing SNA and BP (2, 28, 32, 33 ] (43) and may thereby enhance the firing activity of Na ϩ -sensitive neurons in the PVN (10). In our previous study (10), infusion of Na ϩ -rich aCSF directly into the PVN of Wistar rats caused [Na ϩ ]-dependent increases in BP and HR, and this effect was mediated by local angiotensin type 1 (AT 1 ) receptor stimulation. Aldosterone and a subpressor dose of ouabain in the PVN did not affect BP and HR but enhanced responses to Na ϩ -rich aCSF. The enhancement by aldosterone could be prevented by a mineralocorticoid receptor (MR) blocker, benzamil, or Fab fragments binding "ouabain." Infusion of an AT 1 receptor blocker into the PVN fully prevented the pressor responses to local infusion of ouabain or Na ϩ -rich aCSF combined with aldosterone, suggesting that the MR-benzamil-blockable Na ϩ influx-"ouabain" pathway may enhance Na ϩ -induced AT 1 receptor-mediated responses in the PVN (10).
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The PVN is under tonic inhibition by nitric oxide (NO), since inhibition of NO production in the PVN by local injection of a NO synthase (NOS) blocker increases SNA, BP, and HR (48) . Decreases in SNA and BP induced by a NO donor in the PVN were inhibited by a GABA A receptor antagonist, while perfusion of the PVN with NO increased local GABA release, together suggesting that NO in the PVN tonically inhibits SNA and BP by increasing local GABA release and GABA A receptor activation (13, 49) . Electrophysiological studies provide evidence that NO enhances GABA release from GABAergic nerve terminals presynaptic to spinally projecting neurons in the PVN (27, 29) . A GABA A receptor blocker in the PVN increases local glutamate release (30) , and pressor and sympathetic responses of a GABA A receptor blocker in the PVN can be prevented by a glutamate receptor blocker (30) , indicating that GABA in the PVN tonically inhibits local glutamate release. Enhanced responses to neuronal stimulation in the PVN of Dahl S rats may therefore reflect enhanced activation of excitatory mechanisms and/or less activation of inhibitory mechanisms. We hypothesized that an enhanced neuronal responsiveness to Na ϩ exists in the PVN of Dahl S rats compared with its salt-resistant control strain (Dahl R), and this enhanced sensitivity depends on enhanced MR-benzamil-blockable Na ϩ influx-"ouabain" activity. Additionally, we hypothesized that Na ϩ in the PVN causes less local NO release and less inhibition of sympathoexcitatory neurons in the PVN of Dahl S than R rats, thereby contributing to enhanced pressor responses to Na ϩ in Dahl S rats. The objectives of the present study were therefore 1) to evaluate whether infusion of Na ϩ -rich aCSF into the PVN causes larger BP and HR responses in Dahl S than R or Wistar rats on a regular-salt diet, 2) to investigate whether MR, benzamil-blockable Na ϩ channels, "ouabain," AT 1 receptors, or NO contributes to these enhanced responses, and 3) to evaluate the effects of a NOS blocker in the PVN on resting BP in Dahl S and R rats on a regular-or high-salt diet.
METHODS
Five-to 6-wk-old male Dahl S (SS/Mcw), Dahl SS.BN13 (saltresistant control, Dahl R), and Wistar rats were obtained from Charles River Breeding Laboratories (Montreal, PQ, Canada). Consomic Dahl SS.BN13 rats are Dahl S rats in which chromosome 13 was substituted by chromosome 13 from salt-resistant Brown Norway rats; they do not develop elevated BP when maintained on a high-salt diet (4). Standard commercial rat chow (0.3%, 120 mol Na ϩ /g) and water were provided ad libitum. Experiments were conducted after animals were acclimatized for 1 wk. All experiments were carried out according to the guidelines of the Canadian Council on Animal Care, which conform to National Institutes of Health guidelines, and were approved by the University of Ottawa Animal Care and Use Committee.
Surgical Procedures
For all experiments, intracerebral cannulations of the PVN were performed 1 wk prior to infusions into the PVN. On the day of the surgery, rats were anesthetized with 2% isoflurane in oxygen. Animals were placed in a stereotaxic head frame, and the skull was leveled between bregma and lambda. A section of the skull was removed, and guide cannulas were positioned unilaterally (right side) or bilaterally 0.5 mm above the PVN according to the rat atlas of Paxinos and Watson (36): 1.8 mm posterior to bregma, 0.4 mm lateral to bregma, and 7.9 mm ventral from the skull. Guide cannulas were prepared from the steel tubing of 23-gauge needles (Becton Dickinson) that was cut to extend ϳ1 cm over the skull when positioned above the PVN. They were secured to the skull with two jeweler's screws and acrylic cement and closed with stainless steel obturators. After 1 wk of recovery, the left femoral artery was cannulated with polyethylene tubing (PE 50/10) filled with heparin (1,000 U/ml in 0.9% NaCl). The left femoral vein was cannulated for intravenous injections. For pain relief, buprenorphine (0.04 mg/kg sc) was administered twice daily for 3 days following cannulations of the PVN and on the day prior to infusions into the PVN for recovery from arterial cannulations.
Experimental Procedures
On the morning after the arterial cannulation, the rats were placed in a small cage, and intra-arterial catheters were connected to a pressure transducer for recordings of BP and HR via a personal computer equipped with AcqKnowledge (ACQ version 3.9) software. Systolic and diastolic pressures were determined as previously described (10) .
An "L"-shaped injection cannula (30 gauge) was lowered unilaterally or bilaterally into the PVN through the fixed guide cannula and extended 0.5 mm past the guide. Injection cannulas were connected by polyethylene tubing to 10-l Hamilton microsyringes mounted on an infusion pump (model 2400-003, Harvard Apparatus). The pump was set to deliver microinjections (200 nl every 30 s) or infusions (300 nl/min). For all experiments, animals were allowed to settle for Ն30 min prior to BP and HR recording. Baseline levels were recorded, and values were determined from the average data of 2-min intervals. At the end of the experiment, rats were euthanized, and Evans blue dye (100 nl) was microinjected into the intracerebral infusion site. Brains were removed, frozen, sectioned using a cryostat (Leica), and stained with neutral red. Infusion sites were considered to be inside the PVN if the midpoint of the dye circle was inside the borders of the PVN (Figs. 1 and 2A1 ). Only data from rats with microinjection sites within the PVN were used for analysis. The percentage of injection sites within the PVN was 75-90% for groups with unilateral infusions and 60 -70% for groups with bilateral infusions into the PVN. For infusions into the PVN, the extent of tissue damage from the cannula was limited to the diameter of the circular injection cannula lowered into the PVN (Fig. 2A2 ). For evaluation of the distribution of infusions into the PVN, Evans blue dye (1%) dissolved in vehicle (aCSF) was infused at 300 nl/min for 5 and 10 min into Dahl S rats. Consistent with our previous studies in Wistar rats (10), the dye was distributed largely within the PVN region after 5 min and extended beyond the PVN after 10 min (Fig. 2B ).
Vehicles and Drugs
aCSF [121 mM NaCl, 3.4 mM KCl, 1.2 mM MgCl 2, 0.6 mM NaH2PO4, 29 mM NaHCO3, and 3.4 mM glucose (pH 7.4); osmolarity 296 mosmol/kgH2O] was used as vehicle, except for benzamil (15:85 propylene glycol-aCSF) and eplerenone (1:99 acetonitrileaCSF). All injected compounds were purchased from Sigma or received as gifts (see ACKNOWLEDGMENTS). 8 ]vasopressin (30 g/ kg) dissolved in 0.3 ml of saline (0.145 M Na ϩ ) was injected intravenously, and the animals were allowed to rest for 5 min prior to unilateral infusion of 0.7 M Na ϩ -rich aCSF at 300 nl/min for 15 min. After 45 min of rest to allow BP to return to baseline, a 10-fold higher dose of eplerenone (200 ng·300 nl Ϫ1 ·min Ϫ1 for 10 min) or vehicle was infused into the PVN, the AVP antagonist was injected, and Na ϩ -rich aCSF infusion was repeated as previously described. Doses of eplerenone and the AVP antagonist were adapted from our previous studies (10, 41) .
Experimental Protocols
Benzamil, Fab fragments, losartan, and Na ϩ -rich aCSF in the PVN. To assess whether benzamil-blockable Na ϩ channels, "ouabain," or AT1 receptors mediate the enhanced pressor responses to Na ϩ in the PVN of Dahl S vs. R rats, benzamil (50 ng·300 nl Ϫ1 ·min Ϫ1 for 10 min), "ouabain"-binding Fab fragments (1 g·300 nl Ϫ1 ·min Ϫ1 for 10 min), losartan (3 g·300 nl Ϫ1 ·min Ϫ1 for 15 min), or vehicle was infused unilaterally into the PVN of Dahl S and R rats. Each animal received only one pretreatment. Animals were allowed to rest for 10 min prior to unilateral infusion of 0.7 M Na ϩ -rich aCSF at 300 nl/min for 15 min. To assess whether longer rest periods were needed to reverse binding of "ouabain" from the Na ϩ -K ϩ -ATPase (1, 17, 24), rest periods between infusion of Fab fragments and Na ϩ -rich aCSF were extended to 2, 6, or 18 h in other groups of Dahl S rats. Doses of Fab fragments, benzamil, and losartan were adapted from our previous study showing blockade of the enhancement by aldosterone of the pressor responses to unilateral infusion of Na ϩ -rich aCSF into the PVN of Wistar rats (10) .
L-NAME and Na ϩ -rich aCSF in the PVN. To evaluate whether an acute increase in [Na ϩ ] in the PVN increases local NO activity less in Dahl S than R rats, 0.7 M Na ϩ -rich aCSF was infused unilaterally into the PVN at 300 nl/min for 10 min alone or with the nonspecific NOS inhibitor N -nitro-L-arginine methyl ester hydrochloride (L-NAME) at 27 g·300 nl Ϫ1 ·min Ϫ1 . At 45 min after the end of these infusions, when BP had returned to baseline, 0.7 M Na ϩ -rich aCSF alone or with L-NAME at 54 g·300 nl Ϫ1 ·min Ϫ1 was infused into the PVN for 10 min. Doses of L-NAME were based on preliminary dose-response experiments in Wistar rats (data not shown) and on previous studies measuring pressor responses to L-NAME in the PVN of rats (49) .
Ouabain and ANG II in the PVN. To assess whether ouabain in the PVN causes the same pressor responses in Dahl S and R rats, vehicle was first microinjected unilaterally into the PVN. After 20 min of rest, ouabain was microinjected unilaterally into the PVN at increasing doses (40, 80, and 160 ng). Microinjections were performed at 30-to 45-min intervals between doses of ouabain that corresponded to the period needed for BP and HR to return to baseline. To evaluate whether cross talk between the left and right side of the PVN influences the pressor responses to ouabain in the PVN of rats, vehicle was first microinjected bilaterally into the PVN of Dahl S and R rats. After 20 min of rest, ouabain (80 ng/side) was microinjected bilaterally into the PVN of Dahl rats. To investigate whether the pressor responses to ANG II in the PVN vary in Dahl S vs. R rats, ANG II (90 ng/side) was microinjected 45 min after bilateral injection of ouabain. Doses of ouabain and ANG II in the PVN were adapted from our previous study (10) .
L-NAME in the PVN of Dahl rats on regular-or high-salt diet. To evaluate whether a high-salt diet causes differential NO activity in the PVN of Dahl S vs. R rats, Dahl S and R rats were fed Research Diet D10001 (AIN-76A) regular-NaCl (0.1%, 44 mol Na ϩ /g) or highNaCl (8%, 1,408 mol Na ϩ /g) diet for 3-4 wk. The regular-and high-NaCl diets are the same, except for the NaCl content. Unilateral cannulations of the PVN were performed 2-3 wk after start of the diets, and 1 wk later the femoral artery was cannulated. On the morning after arterial cannulations, L-NAME (27 g·300 nl Ϫ1 ·min Ϫ1 ) was infused unilaterally into the PVN for 10 min. At 45 min after the end of this infusion, L-NAME (54 g·300 nl Ϫ1 ·min Ϫ1 ) was infused into the PVN for 10 min.
Statistical Analysis
Values are means Ϯ SE. Two-way ANOVA followed by a StudentNewman-Keuls post hoc multiple comparison was used for comparison among treatments and rat strains. For testing peak changes from baseline, paired t-tests were used. One-way ANOVA with repeated measures followed by Dunnett's test was used to test the time course of changes from baseline. One-or two-way ANOVA followed by a Student-Newman-Keuls post hoc multiple comparison was used for pair-wise comparisons of the area under the curve. The level of significance was set at P Ͻ 0.05.
RESULTS
Resting MAP tended to be high in Dahl S vs. R rats on the regular-salt diet (Tables 1 and 2 ). The high-salt diet for 3 wk significantly increased resting MAP by ϳ35 mmHg in Dahl S, but not R, rats. HR did not differ among groups (Table 2) . Baseline MAP and HR were not significantly changed by the different pretreatments into the PVN prior to infusion of Na ϩ -rich aCSF (Tables 1 and 2 ).
Na ϩ -Rich aCSF in the PVN
Unilateral infusion of Na ϩ -rich aCSF into the PVN caused concentration-dependent increases in MAP and HR in Dahl S, R, and Wistar rats. In all strains, MAP increased within 3-7 min and reached maximum by 10 min. HR decreased for the first few minutes and then increased to levels significantly higher than the resting level, reaching maximum by 12-14 min. MAP and HR returned to baseline within 20 -30 min after the end of infusion (Fig. 3) . As shown in Figs. 3 and 4, 0.3 M Na ϩ -rich aCSF caused 15-40% and 0.7 M Na ϩ -rich aCSF caused 30 -40% larger peak increases in MAP and HR in Dahl S than R or Wistar rats. Infusion of Na ϩ -rich aCSF at sites outside the PVN (Fig. 1 ) caused minor nonsignificant increases in MAP and HR in Dahl S (4 Ϯ 2 mmHg and 8 Ϯ 4 beats/min, n ϭ 3), Dahl R (3 Ϯ 1 mmHg and 9 Ϯ 4 beats/min, n ϭ 3), and Wistar (2 Ϯ 1 mmHg and 8 Ϯ 3 beats/min, n ϭ 4) rats.
MR, Vasopressin, and Na ϩ -Rich aCSF in the PVN
Unilateral infusion of 0.7 M Na ϩ -rich aCSF into the PVN caused the same peak increases in MAP and HR after local pretreatment with vehicle or eplerenone at the low dose of 200 ng in Dahl S and R rats (data not shown). Eplerenone at the high dose of 2 g and AVP antagonist similarly did not affect the peak pressor responses to Na ϩ -rich aCSF in both strains (Fig. 5) . Na ϩ -rich aCSF no longer caused an initial decrease in HR in rats injected with AVP antagonist compared with rats treated with Na ϩ -rich aCSF alone (i.e., without AVP antagonist; Fig. 3 ). There were no differences between peak MAP and HR responses to the first and second infusions of Na ϩ -rich aCSF into the PVN of Dahl R (14 Ϯ 2 vs. 15 Ϯ 2 mmHg and 57 Ϯ 6 vs. 51 Ϯ 5 beats/min) and S (22 Ϯ 2 vs. 21 Ϯ 1 mmHg and 80 Ϯ 9 vs. 73 Ϯ 6 beats/min) rats (P Ͼ 0.05). Unilateral infusion of vehicle for 10 min at sites outside the PVN (Fig. 1 ) caused nonsignificant changes in MAP and HR in Dahl S (Ϫ1 Ϯ 2 mmHg and Ϫ2 Ϯ 6 beats/min, n ϭ 3) and R (1 Ϯ 2 mmHg and 2 Ϯ 9 beats/min, n ϭ 2) rats.
Benzamil, Fab Fragments, Losartan, L-NAME, and Na ϩ -Rich aCSF in the PVN
Unilateral infusion of benzamil, Fab fragments, or vehicle into the PVN of Dahl S and R rats did not affect peak MAP and HR responses to local infusion of 0.7 M Na ϩ -rich aCSF (Fig.  5) . When resting periods between infusion of Fab fragments and Na ϩ -rich aCSF were extended from 10 min to 2, 6, or 18 h, Fab fragments also did not affect peak MAP (22 Ϯ 2, 20 Ϯ 1, and 20 Ϯ 2 mmHg at 2, 6, and 18 h, respectively) and HR (71 Ϯ 6, 62 Ϯ 4, and 64 Ϯ 7 beats/min at 2, 6, and 18 h, respectively) responses to Na ϩ -rich aCSF in Dahl S rats (n ϭ 3, 5, and 3). In contrast, losartan fully prevented the MAP and HR responses to 0.7 M Na ϩ -rich aCSF in the PVN of Dahl S and R rats (Fig. 5) .
L-NAME and Na ϩ -Rich aCSF in the PVN
The time courses of the MAP response to Na ϩ -rich aCSF or Na ϩ -rich aCSF ϩ L-NAME were similar in Dahl S and R rats, whereas HR increased faster in response to L-NAME ϩ Na ϩ -rich aCSF than Na ϩ -rich aCSF (Fig. 6 ). L-NAME at both doses significantly enhanced MAP and HR responses to 0.7 M Na ϩ -rich aCSF in the PVN of Dahl S and R rats (Figs. 6 and 7) . The enhancement in MAP by L-NAME was larger in Dahl R [ϩ11 mmHg (ϩ79%) and ϩ15 mmHg (ϩ107%) at 270 and 540 g, respectively] than S [ϩ4 mmHg (ϩ20%) and ϩ10 mmHg (ϩ50%) at 270 and 540 g, respectively] rats. Similarly, increases in HR responses were larger in Dahl R [ϩ60 beats/ min (ϩ171%) and ϩ56 beats/min (ϩ160%) at 270 and 540 g, respectively] than S [ϩ32 beats/min (ϩ46%) and ϩ37 beats/ min (ϩ53%) at 270 and 540 g, respectively] rats. As a result, the absolute MAP and HR responses to Na ϩ -rich aCSF ϩ L-NAME were no longer significantly different between the two strains (Figs. 6 and 7).
Ouabain and ANG II in the PVN
Unilateral microinjection of ouabain into the PVN of Dahl S and R rats caused dose-related increases in MAP and HR (Fig. 8) . 
Values are means Ϯ SE. MAP, mean arterial pressure; HR, heart rate; PVN, paraventricular nucleus; aCSF, artificial cerebrosinal fluid. Second baseline was recorded 10 min after the end of infusion of pretreatments. *P Ͻ 0.05 vs. Dahl R. L-NAME (270 g), L-NAME (540 g) on 3 wk regular-salt diet 4 98 Ϯ 4 400 Ϯ 12 100 Ϯ 3 403 Ϯ 11 L-NAME (270 g), L-NAME (540 g) on 3 wk high-salt diet In both strains, MAP and HR decreased for the first 4 -6 min and then increased to levels significantly higher than the resting level. Peak increases in MAP and HR occurred within 6 -12 min, and both returned to baseline within 45 min after injection of ouabain. Pressor responses to unilateral injection of ouabain (40, 80, or 160 ng) were not significantly different between Dahl S and R rats (Fig. 8) . Bilateral injections were performed to assess whether cross talk between the left and right side of the PVN may prevent differences between the two strains. Bilateral microinjection of ouabain (80 ng/side) into the PVN also caused the same increases in MAP and HR in Dahl S and R rats (Fig. 8) . Compared with unilateral microinjection of ouabain, bilateral microinjection of ouabain at an equivalent dose per side (80 ng) caused nearly twofold larger increases in MAP and HR (Fig. 8) . The time course of changes in MAP and HR was similar for unilateral and bilateral injections of ouabain (data not shown). Bilateral injection of ouabain (80 ng/side) outside the PVN (Fig. 1 ) caused small increases in MAP and HR in Dahl S (7 Ϯ 2 mmHg and 24 Ϯ 4 beats/min, n ϭ 3) and R (5 Ϯ 2 mmHg and 17 Ϯ 5 beats/min, n ϭ 3) rats. Bilateral microinjection of ANG II (90 ng/side) into the PVN of Dahl S and R rats increased MAP and HR (Fig. 8) . Increases in MAP and HR occurred within 1 min and peaked within 5 min. MAP and HR returned to baseline within 45 min (data not shown). MAP and HR responses to ANG II in the PVN were not significantly different between Dahl S and R rats (Fig. 8) . Bilateral injection of ANG II (90 ng/side) outside the PVN (Fig. 1) caused only minor nonsignificant changes in MAP and HR in Dahl S (4 Ϯ 2 mmHg and 7 Ϯ 5 beats/min, n ϭ 3) and R (4 Ϯ 1 mmHg and Ϫ2 Ϯ 6 beats/min, n ϭ 3) rats. Bilateral injection of vehicle at sites outside the PVN also caused only minor changes in MAP and HR in Dahl S (2 Ϯ 2 mmHg and 12 Ϯ 8 beats/min, n ϭ 3) and R (1 Ϯ 2 mmHg and 15 Ϯ 5 beats/min, n ϭ 3) rats.
L-NAME in the PVN of Dahl Rats on Regular-or High-Salt Diet
Infusion of L-NAME (270 or 540 g) over 10 min increased MAP and HR within 2-3 min, with maximum reached by 15 min in both strains (Fig. 9 ). MAP and HR returned to baseline within 15-20 min after the end of the infusion (Fig. 9) . Infusion of L-NAME into the PVN caused the same increases in MAP and HR in Dahl S and R rats on the regular-salt diet and in Dahl R rats on the regular-and high-salt diets (Figs. 9 and 10) . However, L-NAME-induced increases in MAP were significantly lower in Dahl S rats on the high-than the regular-salt diet or than in Dahl R rats on either diet (Figs. 9 and 10 ).
Increases in MAP by L-NAME in the PVN were attenuated by ϳ30% in Dahl S vs. R rats on the high-salt diet (Fig. 10) . In contrast, HR responses were not significantly affected by the high-salt diet in Dahl S rats. Infusion of L-NAME (540 g) at sites outside the PVN (Fig. 1) caused nonsignificant increases in MAP and HR in Dahl S (3 Ϯ 3 mmHg and 18 Ϯ 7 beats/min, n ϭ 3) and R (1 Ϯ 2 mmHg and 7 Ϯ 6 beats/min, n ϭ 3) rats on the regular-salt diet. MAP and HR responses to L-NAME at sites outside the PVN were not significantly different in Dahl S and R rats on the high-vs. the regular-salt diet (data not shown). 
DISCUSSION
The present study shows new findings that infusion of Na ϩ -rich aCSF into the PVN causes [Na ϩ ]-dependent increases in BP and HR that are significantly larger in Dahl S than R and Wistar rats, whereas responses to ouabain, ANG II, or L-NAME in the PVN are the same. Losartan blocked all responses to Na ϩ in Dahl S and R rats, whereas L-NAME enhanced them more in Dahl R than S rats, thereby equalizing the responses in the two strains. Pressor responses to L-NAME in the PVN were attenuated by the high-salt diet in Dahl S, but not R, rats. The results suggest that BP and HR responses to [Na ϩ ] in the PVN of Dahl S and R rats are mediated by AT 1 receptor activation. Acute and chronic increases in [Na ϩ ] in the PVN appear to inhibit NO release in the PVN of Dahl S, but not R, rats, thereby contributing to the enhanced pressor responses to Na ϩ and, presumably, dietary salt-induced hypertension in Dahl S rats.
Na ϩ -Rich aCSF and ANG II in the PVN
High-salt intake increases CSF [Na ϩ ] in Dahl S, but not R or Wistar, rats (18, 35) . To assess responsiveness to Na ϩ , Na ϩ -rich aCSF was chronically infused intracerebroventricularly in Dahl S and R rats on the regular-salt diet to raise CSF [Na ϩ ] to levels in Dahl S rats on the high-salt diet (20) . A chronic increase in CSF [Na ϩ ] will also increase tissue [Na ϩ ] (43) and, thereby, activate, e.g., sympathoexcitatory neurons in the PVN (10) . In the present study, we first assessed whether this enhanced responsiveness to Na ϩ exists in the PVN of Dahl S vs. R and Wistar rats.
In Wistar (10) and Dahl rats, unilateral infusion of Na ϩ -rich aCSF into the PVN causes concentration-related increases in BP and HR. These responses are likely mediated by changes in [Na ϩ ] and not osmolality or a volume-induced stretch, since infusion of mannitol at equivalent osmolality or aCSF at the same volume into the PVN of Wistar rats caused no significant changes in BP or HR (10, 22) . Similar to our previous findings in Wistar rats (10) , losartan blocked all responses to Na ϩ -rich Fig. 7 . Peak MAP and HR responses to unilateral infusion of 0.7 M Na ϩ -rich aCSF or 0.7 M Na ϩ -rich aCSF ϩ L-NAME at 270 and 540 g in the PVN of Dahl S and R rats. A 45-min recovery period was allowed between infusion of Na ϩ -rich aCSF ϩ L-NAME at 270 and Na ϩ -rich aCSF ϩ L-NAME at 540 g. Values are means Ϯ SE. MAP and HR responses were significantly different (by 2-way ANOVA) between rat strains [F ϭ 4.7 (MAP) and F ϭ 12.2 (HR); P ϭ 0.012 (MAP) and P ϭ 0.003 (HR), Dahl S vs. R rats with 0.7 M Na ϩ -rich aCSF] and between treatments in the PVN [F ϭ 22.0 (MAP) and F ϭ 33.7 (HR); P Ͻ 0.001 (MAP and HR), 0.7 M Na ϩ -rich aCSF vs. 0.7 M Na ϩ -rich aCSF ϩ L-NAME (270 or 540 g) in Dahl R; P ϭ 0.005 (MAP) and P ϭ 0.001 (HR), 0.7 M Na ϩ -rich aCSF vs. 0.7 M Na ϩ -rich aCSF ϩ L-NAME (540 g) in Dahl S]. *P Ͻ 0.05 vs. baseline. #P Ͻ 0.05 vs. Dahl R.
a P Ͻ 0.05 vs. 0.7 M Na ϩ -rich aCSF. (26), causing AVP release (37), thereby enhancing sympathoinhibitory baroreflex function (12) . This effect may explain why the initial decrease in HR from Na ϩ -rich aCSF in the PVN was prevented by an AVP antagonist but does not appear to influence the pressor responses, since the AVP antagonist did not affect the increases in BP.
Infusion of Na
ϩ -rich aCSF into the PVN caused up to 40% larger increases in BP and HR in Dahl S than R or Wistar rats. Losartan also fully blocked the pressor responses to Na ϩ -rich aCSF in Dahl S rats, indicating that the enhanced pressor responses to Na ϩ in the PVN of Dahl S rats also depend on AT 1 receptor activation. ANG II in the PVN caused the same pressor responses in Dahl S and R rats, indicating that responses to AT 1 receptor activation in the PVN per se are the same in Dahl S and R rats. The larger effect in Dahl S rats therefore likely reflects enhanced ANG II release by Na ϩ . Subsequent experiments investigated mechanisms potentially contributing to this difference.
MR-Benzamil-Blockable Na ϩ Channel-"Ouabain" Pathway in the PVN
In a series of experiments, we established that the aldosterone-MR-Na ϩ channel-"ouabain" pathway mediates the sympathoexcitation and hypertension in Dahl S rats on the high-salt diet or in response to intracerebroventricular infusion of Na ϩ -rich aCSF (15, 21, 41) . Since aldosterone increases hypothalamic "ouabain" only in Dahl S rats (19) and both aldosterone and ouabain enhance responses to Na ϩ (10), this pathway may contribute to the enhanced responses to Na ϩ in Dahl S rats. Increased release of a neuromodulator such as "ouabain" may lead to more binding to the Na neurons, increasing intracellular Ca 2ϩ and, thereby, possibly activating ANG II release (7) . Intracerebroventricular (16, 20) and unilateral and bilateral microinjection of ouabain into the PVN caused the same dose-related increases in BP and HR in Dahl S and R rats, indicating that increased responses to ouabain and, presumably, "ouabain" do not contribute to the enhanced responses to Na ϩ infused intracerebroventricularly or into the PVN of Dahl S rats. Our findings show that eplerenone, benzamil, and Fab fragments do not affect the pressor responses to Na ϩ -rich aCSF in the PVN of Dahl S and R rats, suggesting that MR, benzamil-blockable Na ϩ channels, and "ouabain" are not involved in mediating the pressor responses to Na ϩ in the PVN of Dahl R rats or in the enhanced pressor responses in Dahl S rats. Doses of eplerenone, benzamil, and Fab fragments were similar to those used in our previous study to block the enhancement of the pressor responses to Na ϩ -rich aCSF in the PVN by aldosterone (10) . Fab fragments bind free "ouabain," leading to dissociation of "ouabain" from the enzyme. In Dahl S rats on a high-salt diet, Fab fragments injected intracerebroventricularly began to reverse hypertension at 4 h (17); in in vitro studies, addition of Fab fragments for 1 h did not reverse "ouabain"-mediated inhibition of 86 Rb uptake (via Na ϩ -K ϩ -ATPase) by erythrocytes but did reverse the inhibition when the incubation was extended for 12 h (1). After the time between Fab fragments and Na ϩ -rich aCSF was extended to 2, 6, or 18 h, the pressor responses to Na ϩ remained enhanced, further supporting the notion that "ouabain" is not involved in the enhanced pressor responses to Na ϩ in the PVN of Dahl S rats on the regular-salt diet. These findings indicate that the aldosterone-"ouabain" pathway does not contribute to the enhanced responsiveness to a short-term increase in Na ϩ in the PVN of Dahl S rats on the regular-salt diet. Activation of this pathway in the PVN may require a more chronic increase in [Na ϩ ] and may contribute to the increase in resting BP and a further increase in neuronal responsiveness to Na ϩ in Dahl S rats on the high-salt diet. Acute infusion of blockers of this pathway in the PVN may not last long enough to cause sufficiently long inhibition of these "slow" mechanisms, and chronic local infusions likely will affect/destroy neurons. As an alternative approach, injection of an adeno-associated virus carrying a short-hairpin small-interference RNA against, e.g., MR, into the PVN was recently suggested to achieve long-term inhibition (45) .
Neuronal NOS in the PVN
Consistent with previous studies (48) , the NOS blocker L-NAME in the PVN increased BP and HR. L-NAME is a nonspecific inhibitor of NOS but is more specific for neuronal NOS (nNOS) and endothelial NOS than inducible NOS (40) . BP and HR responses to infusion of L-NAME into the PVN were inhibited by 88% in rats in which a dominant-negative construct against nNOS was injected into the PVN (38) . These findings suggest that responses to L-NAME in the PVN are predominantly mediated by nNOS inhibition, decreasing local NO production and, thereby, disinhibiting the PVN. Responses to L-NAME were the same in Dahl S and R rats on a regularsalt diet, suggesting that NO release in the PVN is similar in the two strains on a regular-salt diet. These functional findings are consistent with previous studies showing that mRNA expression of nNOS is the same in the PVN of Dahl S and R rats on a regular-salt diet (39) .
L-NAME enhanced responses to Na ϩ -rich aCSF more in Dahl R than S rats and equalized their responses to Na ϩ . In Dahl R rats, the combined increases in BP or HR from L-NAME ϩ Na ϩ -rich aCSF in the PVN were similar to the sum of those from L-NAME and Na ϩ -rich aCSF alone, suggesting that Na ϩ did not change NOS or NO activity in the PVN of this strain. In contrast, in Dahl S rats, responses to L-NAME ϩ Na ϩ -rich aCSF in the PVN were smaller than the sum of each alone. These findings suggest that an acute increase in [Na ϩ ] in the PVN inhibits local NO release in Dahl S rats, causing larger BP increases in response to Na ϩ . In Dahl S rats, a decrease in NO in the PVN caused by Na ϩ may cause less local GABA release (13, 49) . A GABA A receptor blocker in the PVN increases SNA and BP (30, 49) , and this effect can be mostly prevented by an AT 1 receptor blocker (3), suggesting that GABA release in the PVN tonically inhibits SNA and BP, an effect that depends on local AT 1 receptor activation. A decrease in GABA release may cause less GABA A receptor Fig. 10 . Peak MAP and HR responses to unilateral infusion of L-NAME (27 or 54 g/min) for 10 min into the PVN of Dahl S and R rats on regular-or high-salt diet. For each rat, a 45-min recovery period was allowed between the 2 infusions of L-NAME. Values are means Ϯ SE. By 2-way ANOVA, MAP responses to L-NAME (270 g) were significantly different by interactions between rat strain and diet (F ϭ 4.8; P ϭ 0.018, Dahl S vs. R on high-salt diet; P ϭ 0.016, high-vs. regular-salt diet in Dahl S). MAP responses to L-NAME (540 g) were significantly different by strain and diet (F ϭ 7.1 and 6.1; P ϭ 0.005, Dahl S vs. R on high-salt diet; P ϭ 0.01, high-vs. regular-salt diet in Dahl S). HR responses to L-NAME at both doses were not significantly different between rat strains or diet treatments. *P Ͻ 0.05 vs. baseline. #P Ͻ 0.05 vs. L-NAME (270 or 540 g) ϩ regular-salt diet.
a P Ͻ 0.05 vs. Dahl R with L-NAME at 54 g/min.
activation on angiotensinergic neurons in the PVN, thereby disinhibiting local ANG II release. This effect of Na ϩ on GABA and ANG II release in the PVN of Dahl S rats would enhance local AT 1 receptor activation, further increasing the activity of sympathoexcitatory neurons, thereby contributing to the enhanced pressor responses. Na ϩ in the PVN causes local ANG II release (7), while ANG II in the PVN increases local NO release (31), enhancing local GABA release, thereby inhibiting the PVN (13) . A dysfunction in this ANG II-NO-GABA negative feedback in Dahl S rats unlikely contributes to inhibition of NO release in the PVN by a local increase in Na ϩ , since pressor responses to ANG II in the PVN were the same in Dahl S and R rats.
High-salt diet attenuated pressor responses to L-NAME in the PVN of Dahl S, but not R, rats. These findings are consistent with those from acute infusions of Na ϩ and L-NAME in the PVN (see above) and suggest that high-salt intake inhibits NO release in the PVN of Dahl S, but not R, rats. Similar to acute increases in ] cause differential NO release in the PVN of Dahl S vs. R rats, BP responses to L-NAME in the PVN of Dahl S and R rats chronically intracerebroventricularly infused with Na ϩ -rich aCSF need to be assessed. Since chronic intracerebroventricular infusion of Na ϩ -rich aCSF causes nearly threefold larger BP increases in Dahl S than R rats (20) , we expect that chronic intracerebroventricular infusion of Na ϩ -rich aCSF also inhibits local NO release in Dahl S, but not R, rats, causing attenuated BP responses to L-NAME in the PVN of Dahl S rats. A high-salt diet increases mRNA expression of nNOS in the PVN of Dahl S and R rats, but the increase is nearly twofold larger in Dahl S rats (39) . To our knowledge, no studies have assessed whether a high-salt diet causes parallel increases in nNOS protein expression and NO activity in the PVN in Dahl S and R rats. A high-salt diet increases AT 1 receptor densities in the PVN of Dahl S and, to a lesser extent, R rats (44) . An increase in AT 1 receptor stimulation in the PVN may enhance local release of superoxide anions (8), scavenging NO (25, 47) and decreasing its effectiveness in Dahl S rats.
Together, our results indicate that an enhanced pressor response to Na ϩ is present in the PVN of Dahl S vs. R rats and is mediated by enhanced ANG II release and AT 1 receptor activation. An acute and a chronic increase in Na ϩ by high-salt intake may inhibit NO release in the PVN of Dahl S, but not R, rats, contributing to the enhanced pressor responses to Na ϩ and, presumably, to dietary salt-induced hypertension in Dahl S rats.
Limitations
The actual levels of Na ϩ in the PVN of Dahl S rats on a high-salt diet have not been defined. It is difficult to assess whether the quantity of Na ϩ infused into the PVN caused concentrations within or above the pathophysiological range. The actual interstitial [Na ϩ ] depends on the rate of infusion and spread of the infusion throughout the PVN, as well as the concentration of the perfusate. Na ϩ -rich aCSF infused into the PVN may spread and stimulate sympathoexcitatory neurons outside the PVN. However, the distribution of Evans blue dye was largely within the PVN after infusion for 5 min, when BP and HR responses to Na ϩ were clearly apparent, and infusions in the vicinity of the PVN did not significantly increase BP or HR.
The anesthesia and (minor) surgery within 24 h of experimental manipulation may alter central regulation of BP. To minimize possible differential effects on Dahl S vs. R rats, all conditions, including the time of arterial cannulation surgeries (performed for 15-20 min in the early afternoon) and experiments (performed on the next morning), were kept the same in both strains. A majority of studies from other laboratories performing injections into the PVN and BP recordings were conducted after acute surgery under anesthesia (9, 30, 46, 50) . These experimental approaches appear clearly less desirable. One may be concerned about manipulations of conscious rats for injections into the PVN. However, in all protocols, vehicle controls had no effect on BP or HR when infused inside or in the vicinity of the PVN.
Perspectives and Significance
The pathophysiological relevance of Na (43) and, thereby, may decrease NO activity in the PVN and enhance its neural responsiveness to Na ϩ . Future studies need to assess whether a decrease in NO activity by Na ϩ in the PVN of Dahl S rats on a high-salt diet enhances local AT 1 receptor activation and whether these mechanisms in the PVN contribute to the elevated SNA and BP.
